- Home | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Biogen - Wikipedia
Biogen Inc is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide
- Biogen Inc. (BIIB) Stock Price, News, Quote History - Yahoo . . .
Biogen Inc discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally
- Biogen Announces $2 Billion Manufacturing Investment in North . . .
Biogen has invested approximately $10 billion in its North Carolina manufacturing footprint to date, including more than $3 billion in recent years, and this upcoming investment will fuel the continued advancement of Biogen’s late-stage clinical pipeline
- Biogen Commits $2B To Expand US Drug Production Amid Tariff . . .
Biogen said it will expand its antisense oligonucleotide capabilities and infrastructure and establish multi-platform fill-finish capabilities at clinical and commercial scales The biotech will also continue to modernize its manufacturing technologies and controls, including by investing in advanced automation and artificial intelligence
- Biogen to invest $2 billion in RTP, open new factory in 2025
Biogen Inc has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), marking its 30th anniversary at the location
- Biogen
Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world
|